首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1677901

更年期市場規模、佔有率、成長分析、按治療方法、產品類型、適應症、分銷挑戰、年齡層和地區分類 - 行業預測 2025-2032

Menopause Market Size, Share, and Growth Analysis, By Treatment (Dietary Supplements, OTC Pharma Products), By Product Type (Gel, Injection), By Indication, By Distribution Challenge, By Age Group, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月05日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2023 年全球更年期疾病市場規模將達到 186 億美元，從 2024 年的 197.2 億美元成長到 2032 年的 314.2 億美元，預測期內（2025-2032 年）的複合年成長率為 6.0%。

更年期市場正在崛起，反映出人們對緩解更年期症狀（如潮熱、盜汗和憂鬱等）的產品的認知和需求不斷成長。這種自然的生物學變化發生在 45 歲至 55 歲之間，引發了人們對旨在緩解症狀的膳食補充劑、草藥產品和非處方藥的興趣激增。推動這一成長的因素包括人口老化、健康意識的增強以及向自然和有機解決方案的轉變。 COVID-19 疫情進一步加劇了這些趨勢，擾亂了心理健康，鼓勵女性尋求安全的植物來源荷爾蒙補充療法替代品，並促進了膳食補充劑的使用。這種不斷變化的情況為市場持續擴張提供了機會。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

AbbVie Inc.（USA）
Astellas Pharma Inc.（Japan）
Bayer AG（Germany）
Pfizer Inc.（USA）
Novartis AG（Switzerland）
Merck & Co., Inc.（USA）
Teva Pharmaceutical Industries Ltd.（Israel）
Eli Lilly and Company（USA）
GlaxoSmithKline plc（UK）
Key Developments
Mithra Pharmaceuticals（Belgium）
Dr. Reddy's Laboratories Ltd.（India）
Procter & Gamble（USA）
Unilever（UK）
Pure Encapsulations, LLC（USA）
Rainbow Light（USA）
Kindra（USA）
Elektra Health（USA）

結論和建議

簡介目錄

Product Code: SQMIG35I2115

Global Menopause Market size was valued at USD 18.6 billion in 2023 and is poised to grow from USD 19.72 billion in 2024 to USD 31.42 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

The menopause market is on an upward trajectory, reflecting heightened awareness and demand for products that alleviate menopausal symptoms such as hot flashes, night sweats, and mood swings, experienced by a significant percentage of women. Spanning ages 45 to 55, this natural biological transition has prompted a surge in interest for nutritional supplements, herbal products, and over-the-counter medications designed to ease symptoms. Factors fueling this growth include an aging population, increased health consciousness, and a shift toward natural and organic solutions. The COVID-19 pandemic has further intensified these trends, disrupting mental health and prompting women to seek safe, plant-based alternatives to hormone replacement therapy, resulting in a boost in dietary supplement usage. This evolving landscape signals sustained market expansion opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segments Analysis

Global Menopause Market is segmented by Treatment, Product Type, Indication, Distribution Challenge, Age Group and region. Based on Treatment, the market is segmented into Dietary Supplements and OTC Pharma Products. Based on Product Type, the market is segmented into Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream and Vaginal Ring. Based on Indication, the market is segmented into Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency and Vaginal Dryness. Based on Distribution Challenge, the market is segmented into Hospital Pharmacies, Online Stores and Retail Pharmacies. Based on Age Group, the market is segmented into Premature Menopause, Early Menopause, Average Menopause and Late Menopause. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Menopause Market

The global menopause market is fueled by several key factors, including the aging population, increased awareness, lifestyle changes, and advancements in technology. As life expectancies rise and birth rates decline, more women are entering menopause, creating a substantial demand for menopause-related products and services. For example, the North American Menopause Association reports that about 2 million women in the U.S. go through menopause each year. Additionally, public awareness of menopause symptoms is improving, leading to greater demand for solutions like hormone therapy, herbal supplements, and wellness products. Women are also acknowledging the role of healthy lifestyles in managing menopause symptoms, further driving market growth.

Restraints in the Global Menopause Market

Despite the substantial growth potential in the Global Menopause market, several factors may act as constraints on its expansion. Safety concerns regarding hormone replacement therapy (HRT), particularly its links to increased risks of breast cancer, heart disease, and stroke, are paramount. Consequently, there is a growing demand for non-hormonal alternatives, creating challenges for companies focusing on hormone-based therapies to address these safety issues. Additionally, menopause remains a stigmatized topic in many cultures, leading to a lack of awareness and understanding that can suppress consumer demand and complicate marketing efforts for menopause-related products. Regulatory hurdles impose strict safety and efficacy requirements, further deterring innovation in treatment options. Compounded by insufficient research and development in this field, these factors collectively threaten to hinder the market's advancement.

Market Trends of the Global Menopause Market

The Global Menopause market is witnessing a significant shift towards non-hormonal therapies driven by women's growing apprehension regarding hormone-based treatments and their associated risks. This trend has led to a rising demand for alternative solutions, such as herbal medicines, cognitive-behavioral therapy (CBT), and mindfulness-based interventions, which are perceived as safer options for managing menopausal symptoms. As awareness around holistic health and wellness increases, healthcare providers and companies are focusing on developing and promoting these non-hormonal alternatives, further shaping the market landscape. This evolution highlights a consumer preference for natural and integrative approaches, signaling a transformative era in menopause management strategies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Menopause Market Size by Treatment & CAGR (2025-2032)

Market Overview
Dietary Supplements
OTC Pharma Products
- Hormonal products
- Combination Estrogen and Other Medicines
- Combination Estrogen and Progestin Medicines
- Estrogen-Only Medicines
- Progestin-Only Medicines
- Non-hormonal products

Global Menopause Market Size by Product Type & CAGR (2025-2032)

Market Overview
Gel
Injection
Oral Dosage
Patch
Pill
Powder
Skin Cream
Skin Spray (Transdermal)
Vaginal Cream
Vaginal Ring

Global Menopause Market Size by Indication & CAGR (2025-2032)

Market Overview
Dry Eyes
Dry Skin
Hot Flashes
Mood Swings, Mild depression & Irritability
Night Sweats and Cold Flashes.
Osteoporosis
Trouble Sleeping
Urinary Urgency
Vaginal Dryness

Global Menopause Market Size by Distribution Challenge & CAGR (2025-2032)

Market Overview
Hospital Pharmacies
Online Stores
Retail Pharmacies

Global Menopause Market Size by Age Group & CAGR (2025-2032)

Market Overview
Premature Menopause
Early Menopause
Average Menopause
Late Menopause

Global Menopause Market Size & CAGR (2025-2032)

North America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- US
- Canada
Europe (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
Key Developments
Mithra Pharmaceuticals (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Procter & Gamble (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Unilever (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pure Encapsulations, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rainbow Light (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindra (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elektra Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments